Related to Exploring Biology in Space May See a Slowdown with the End of NASA’s Shuttle Missions

• AVI BioPharma Obtains Expanded DoD Contract Worth $11.5M for Its Junin Virus Infection Treatment
  
• Clemson University Obtains $9.3M for Tissue Regeneration Center
  
• TiGenix Seals $23.8M Share-Based Deal to Buy Orthomimetics
  
• Researchers Generate Fully Functional Epidermis from hESC-Derived Keratinocytes
  
• Amgen to Apply ImmunoGen TAP Technology to Another Cancer Target
  
• Researchers Awarded $2.4M to Study Neuronal Regeneration
  
• Scientists Use Dental Stem Cells to Create New Bone Tissue in Humans
  
• Amgen Takes Over Array’s Type 2 Diabetes Program for $60M Up Front
  
• New U.K. Center for Regenerative Medicine to Receive Over $13M in Funding
  
• TAP and Centre for Innovative Manufacturing in Regenerative Medicine Ink Five-Year Extension
  
• UT-Battelle Licenses Tissue-Regeneration Technologies to NellOne Therapeutics
  
• Investigators Come Up with Virus-Free Technique to Make Stem Cells Pluripotent
  
• Galapagos and MorphoSys Add Fourth Target to Ongoing Alliance in Bone and Joint Diseases
  
• Yecuris Introduces Humanized Mouse Knockout Model for In Vivo Hepatocyte Expansion
  
• SIGA Wins $2.8M DoD Contract to Progress Antiviral into the Clinic
  
• Xcellerex to Develop Single-Use Manufacturing Technology for Humacyte’s Vascular Grafts
  
• T2cure’s Mid-Stage Somatic Stem Cell Product Receives EMEA Quality Certification
  
• Report Confirms Biotech Struggling in the Face of Volatile Capital Markets
  
• Amgen Wins Approval for Osteoporosis Therapy for Postmenopausal Women
  
• Oxeco to Purchase Tissue Regenix in £12M Share-Based Reverse Takeover